{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:23:14Z","timestamp":1777900994441,"version":"3.51.4"},"reference-count":0,"publisher":"S. Karger AG","license":[{"start":{"date-parts":[[2009,8,5]],"date-time":"2009-08-05T00:00:00Z","timestamp":1249430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"},{"start":{"date-parts":[[2009,8,5]],"date-time":"2009-08-05T00:00:00Z","timestamp":1249430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Arch Allergy Appl Imm"],"abstract":"<jats:p>Chemotactic reactivity of eosinophils obtained from the bone marrow (BM-Eo) of cyclophosphamide-treated, Toxocara canis-infected mice was compared to that of eosinophils obtained from the peritoneal cavity (PEC-Eo). BM-Eo responded well to alanyl-tetrapeptide, a synthetic eosinophil chemotactic factor of anaphylaxis (ECF-A), whereas PEC-Eo did not. Both BM-Eo and PEC-Eo showed almost equally high chemotactic reactivity to parasite-derived ECF, ECF lymphokine and complement-derived ECF. Chemotactic reactivity of BM-Eo to synthetic ECF-A was deactivated by preincubation with ECF-A. Unresponsiveness of PEC-Eo to synthetic ECF-A could be explained by chemotactic deactivation by ECF-A, because an ECF-A-like substance was detected in the ascitic fluid; this substance could deactivate the chemotactic reactivity of BM-Eo to synthetic ECF-A. From these results, BM-Eo are naive and seem to be a good indicator for eosinophilotaxis and its modulation.<\/jats:p>","DOI":"10.1159\/000234090","type":"journal-article","created":{"date-parts":[[2009,8,5]],"date-time":"2009-08-05T05:41:56Z","timestamp":1249450916000},"page":"412-416","source":"Crossref","is-referenced-by-count":7,"title":["Chemotactic Reactivity of Eosinophils Obtained from Bone Marrow and Peritoneal Cavity of Cyclophosphamide-Treated, Toxocara canis-Infected Mice"],"prefix":"10.1159","author":[{"given":"Y.","family":"Nawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Owhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2009,8,5]]},"container-title":["International Archives of Allergy and Applied Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/234090","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/karger.com\/article-pdf\/doi\/10.1159\/000234090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:48:18Z","timestamp":1777632498000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000234090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,5]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1159\/000234090","archive":["Portico"],"relation":{},"ISSN":["0020-5915","2571-6662"],"issn-type":[{"value":"0020-5915","type":"print"},{"value":"2571-6662","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,5]]}}}